PALFORZIA

Aimmune Therapeutics🇺🇸 United States

FDA Page

Effective Date: Mar 17, 2023
Approval ID: 17f5be03-6705-4ac9-b8f3-bc4993ebc0eb
Products: 12 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PALFORZIA safely and effectively. See Full Prescribing Information for PALFORZIA. PALFORZIA [Peanut ( ) Allergen Powder-dnfp] Powder for oral administration Initial U.S. Approval: 2020

Quick Stats

Total Products12

Labelers2

Label Sections29

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.